People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zogenix Inc | — | Pharmaceuticals | Series C | $131.2M | $526.4M | 2009 |
| Dare Bioscience, Inc. | — | Biotechnology | Series B | $102.0M | $93.8M | 2017 |
Roger L. Hawley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roger L. Hawley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| John P Ryan | 1 | 11 |
| Cam L. Garner | 1 | 11 |
| Alan Crane | 1 | 9 |
| Terry McGuire | 1 | 8 |
| James C. Blair | 1 | 8 |
| Robert Tepper | 1 | 7 |
| Louis C. Bock | 1 | 7 |
| Bryan E. Roberts | 1 | 6 |
| Steven E. Hall | 1 | 4 |
| Cheryl R. Blanchard | 1 | 4 |
| Alexandra Glucksmann | 1 | 4 |
| Robert E. Langer | 1 | 3 |
| Alex Zisson | 1 | 3 |
| Kurt C. Wheeler | 1 | 3 |
| Erle T. Mast | 1 | 3 |
| Arda M. Minocherhomjee | 1 | 3 |
| Robert E. Tepper | 1 | 2 |
| Ram Sasisekharan | 1 | 2 |
| Ken M. Haas | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.